Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT)

Cellular and Molecular Life Sciences

Volumn 69, Issue 15, 2012, Pages 2515-2526

  Biamonti, Giuseppe ^a   Bonomi, Serena ^a   Gallo, Stefania ^a   Ghigna, Claudia ^a  

^a CNR   (Italy)

Author keywords

Alternative splicing; EMT; Metastasis; RNA binding proteins; Splicing factors; Tumor progression

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; RAC1 PROTEIN;

ALTERNATIVE RNA SPLICING; CELL INVASION; DISEASE ASSOCIATION; ENHANCER REGION; EPITHELIAL MESENCHYMAL TRANSITION; GENE FUNCTION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; PROTO ONCOGENE; RAC1 GENE; REGULATOR GENE; REVIEW; RON GENE; SIGNAL TRANSDUCTION; SILENCER ELEMENT; SRSF1 GENE; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD44; CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MODELS, GENETIC; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROTO-ONCOGENES; RAC1 GTP-BINDING PROTEIN; RECEPTOR PROTEIN-TYROSINE KINASES; RNA-BINDING PROTEINS; TUMOR MICROENVIRONMENT;

EID: 84864367866     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-0931-7     Document Type: Review

References (91)

1. Christofori G (2006) New signals from the invasive front. Nature 441:444-450 (Pubitemid 44050139)
2. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelialmesenchymal transitions in development and disease. Cell 139: 871-890
3. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14:818-829 (Pubitemid 351757205)
4. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9:265-273
5. Grunert S, Jechlinger M, Beug H (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Natl Rev Mol Cell Biol 4:657-665 (Pubitemid 36934968)
6. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483-1487 (Pubitemid 38314410)
7. Timmerman LA, Grego-Bessa J, Raya A, Bertran E, Perez- Pomares JM, Diez J, Aranda S, Palomo S, McCormick F, Izpisuaa-Belmonte JC, de la Pompa JL (2004) Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev 18:99-115 (Pubitemid 38090691)
8. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA (2004) Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431:707-712 (Pubitemid 39382619)
9. Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y(2009) Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15:195-206
10. Ghigna C, Giordano S, Shen H, Benvenuto F, Castiglioni F, Comoglio PM, Green MR, Riva S, Biamonti G (2005) Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol Cell 20:881-890 (Pubitemid 41814877)
11. Valacca C, Bonomi S, Buratti E, Pedrotti S, Baralle FE, Sette C, Ghigna C, Biamonti G (2010) Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J Cell Biol 191:87-99
12. Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S, Guo W, Xing Y, Carstens RP (2010) An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J 29:3286-3300
13. Brown RL, ReinkeLM,DamerowMS, Perez D, Chodosh LA, Yang J, Cheng C (2011) CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 121:1064-1074
14. Ghigna C, Valacca C, Biamonti G (2008) Alternative splicing and tumor progression. Curr Genomics 9:556-570
15. Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72:291-336 (Pubitemid 36930448)
16. Wahl MC, Will CL, Luhrmann R (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136:701-718
17. Blencowe BJ (2006) Alternative splicing: new insights from global analyses. Cell 126:37-47 (Pubitemid 44040990)
18. Schwerk C, Schulze-Osthoff K (2005) Regulation of apoptosis by alternative pre-mRNA splicing. Mol Cell 19:1-13 (Pubitemid 40884653)
19. PanQ, ShaiO,Lee LJ, FreyBJ, Blencowe BJ (2008)Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40:1413-1415
20. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476 (Pubitemid 352759009)
21. Hillier LW, Reinke V, Green P, Hirst M, Marra MA, Waterston RH (2009) Massively parallel sequencing of the polyadenylated transcriptome of C. elegans. Genome Res 19:657-666
22. Stolc V, Gauhar Z, Mason C, Halasz G, van Batenburg MF, Rifkin SA, Hua S, Herreman T, Tongprasit W, Barbano PE, Bussemaker HJ, White KP (2004) A gene expression map for the euchromatic genome of Drosophila melanogaster. Science 306: 655-660 (Pubitemid 39440907)
23. Modrek B, Lee C (2002) A genomic view of alternative splicing. Nat Genet 30:13-19
24. Isken O, Maquat LE (2008) The multiple lives of NMD factors: balancing roles in gene and genome regulation. Nat Rev Genet 9: 699-712
25. Lareau LF, Inada M, Green RE, Wengrod JC, Brenner SE (2007) Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. Nature 446:926-929 (Pubitemid 46633161)
26. Ni JZ, Grate L, Donohue JP, Preston C, Nobida N, O'Brien G, Shiue L, Clark TA, Blume JE, Ares M Jr (2007) Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay. Genes Dev 21:708-718 (Pubitemid 46440292)
27. Hillman RT, Green RE, Brenner SE (2004) An unappreciated role for RNA surveillance. Genome 5:R8
28. Barash Y, Calarco JA, Gao W, Pan Q, Wang X, Shai O, Blencowe BJ, Frey BJ (2010) Deciphering the splicing code. Nature 465:53-59
29. Buratti E, Baralle FE (2004) Influence of RNA secondary structure on the pre-mRNA splicing process. Mol Cell Biol 24: 10505-10514 (Pubitemid 39603113)
30. McManus CJ, Graveley BR (2011) RNA structure and the mechanisms of alternative splicing. Curr Opin Genet Dev 21: 373-379
31. Chen M, Manley JL (2009) Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Natl Rev Mol Cell Biol 10:741-754
32. Wang Z, Burge CB (2008) Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA 14: 802-813 (Pubitemid 351574901)
33. Biamonti G, Riva S (1994) New insights into the auxiliary domains of eukaryotic RNA-binding proteins. FEBS Lett 340:1-8 (Pubitemid 24094346)
34. Smith CW, Valcarcel J (2000) Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem Sci 25:381-388 (Pubitemid 30497249)
35. David CJ, Manley JL (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24:2343-2364
36. He C, Zhou F, Zuo Z, Cheng H, Zhou R (2009) A global view of cancer-specific transcript variants by subtractive transcriptomewide analysis. PLoS One 4:e4732
37. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL, Weinberg RA (2007) Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 104:10069-10074 (Pubitemid 47175264)
38. Le K,MitsourasK,RoyM,Wang Q,Xu Q,Nelson SF, LeeC (2004) Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data. Nucleic Acids Res 32:e180
39. Pan Q, Saltzman AL, Kim YK, Misquitta C, Shai O, Maquat LE, Frey BJ, Blencowe BJ (2006) Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. Genes Dev 20:153-158 (Pubitemid 43112934)
40. Boccaccio C, Comoglio PM (2006) Invasive growth: a METdriven genetic programme for cancer and stem cells. Nat Rev Cancer 6:637-645 (Pubitemid 44140861)
41. Lu Y, Yao HP, Wang MH (2007) Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Cancer Lett 257:157-164 (Pubitemid 47538834)
42. Funakoshi H, Nakamura T (2001) Identification of HGF-like protein as a novel neurotrophic factor for avian dorsal root ganglion sensory neurons. Biochem Biophys Res Commun 283:606-612 (Pubitemid 32917932)
43. Stella MC, Vercelli A, Repici M, Follenzi A, Comoglio PM (2001) Macrophage stimulating protein is a novel neurotrophic factor. Mol Biol Cell 12:1341-1352 (Pubitemid 33044415)
44. Camp ER, Liu W, Fan F, Yang A, Somcio R, Ellis LM (2005) RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Ann Surg Oncol 12:273-281 (Pubitemid 40616491)
45. Zhou YQ, He C, Chen YQ, Wang D, Wang MH (2003) Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential. Oncogene 22:186-197 (Pubitemid 36174176)
46. Wang MH, Lao WF, Wang D, Luo YL, Yao HP (2007) Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain. Cancer Biol Ther 6:1121-1129 (Pubitemid 351574966)
47. Collesi C, Santoro MM, Gaudino G, Comoglio PM (1996) A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol Cell Biol 16:5518-5526 (Pubitemid 26315071)
48. Karni R, de Stanchina E, Lowe SW, Sinha R, Mu D, Krainer AR (2007) The gene encoding the splicing factor SF2/ASF is a protooncogene. Nat Struct Mol Biol 14:185-193 (Pubitemid 46355578)
49. Karni R, Hippo Y, Lowe SW, Krainer AR (2008) The splicingfactor oncoprotein SF2/ASF activates mTORC1. Proc Natl Acad Sci USA 105:15323-15327
50. Lefave CV, Squatrito M, Vorlova S, Rocco GL, Brennan CW, Holland EC, Pan YX, Cartegni L (2011) Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas. EMBO J 30: 4084-4097
51. Tauler J, Zudaire E, Liu H, Shih J, Mulshine JL (2010) hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. Cancer Res 70:7137-7147
52. Golan-Gerstl R, Cohen M, Shilo A, Suh SS, Bakacs A, Coppola L, Karni R (2011) Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. Cancer Res 71:4464-4472
53. Ghigna C, De Toledo M, Bonomi S, Valacca C, Gallo S, Apicella M, Eperon I, Tazi J, Biamonti G (2010) Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives. RNA Biol 7:495-503
54. Bosco EE, Mulloy JC, Zheng Y (2009) Rac1 GTPase: a "Rac" of all trades. Cell Mol Life Sci 66:370-374
55. Jordan P, Brazao R, Boavida MG, Gespach C, Chastre E (1999) Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 18:6835-6839
56. Singh A, Karnoub AE, Palmby TR, Lengyel E, Sondek J, Der CJ (2004) Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 23: 9369-9380 (Pubitemid 40069669)
57. Matos P, Jordan P (2006) RAC1, but not RAC1B, stimulates RELB-mediated gene transcription in colorectal cancer cells. J Biol Chem 281:13724-13732 (Pubitemid 43855288)
58. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M, Lengyel E (2000) Rac1 in human breast cancer: overexpression, mutation analysis and characterization of a new isoform, Rac1b. Oncogene 19:3013-3020 (Pubitemid 30389092)
59. Goncalves V, Matos P, Jordan P (2009) Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways. Hum Mol Genet 18: 3696-3707
60. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469-480
61. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174 (Pubitemid 37328786)
62. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127 (Pubitemid 40966197)
63. Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y (2002) CD44 in cancer. Crit Rev Clin Lab Sci 39:527-579 (Pubitemid 35425379)
64. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Natl Rev Mol Cell Biol 4:33-45 (Pubitemid 36077255)
65. Martin TA, Harrison G, Mansel RE, Jiang WG (2003) The role of the CD44/ezrin complex in cancer metastasis. Crit Rev Oncol Hematol 46:165-186 (Pubitemid 36452345)
66. Sonobe S, Miyamoto H, Nobukawa B, Izumi H, Futagawa T, Ishikawa N, Yamazaki A, Uekusa T, Abe H, Suda K (2005) Prognostic value of CD44 isoform expression in thymic epithelial neoplasms. Cancer 103:2015-2022 (Pubitemid 40605107)
67. Orian-Rousseau V (2010) CD44, a therapeutic target for metastasising tumours. Eur J Cancer 46:1271-1277
68. Heider KH, Kuthan H, Stehle G, Munzert G (2004) CD44v6: a target for antibody-based cancer therapy. Cancer Immunol Immunother 53:567-579 (Pubitemid 38858330)
69. Matter N, Herrlich P, Konig H (2002) Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 420:691-695 (Pubitemid 36764503)
70. Cheng C, Sharp PA (2006) Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol Cell Biol 26:362-370
71. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H (2002) CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 16:3074-3086 (Pubitemid 35424194)
72. Cheng C, Yaffe MB, Sharp PA (2006) A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev 20:1715-1720 (Pubitemid 43992879)
73. Suzuki MM, Bird A (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9:465-476 (Pubitemid 351693975)
74. Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4:143-153 (Pubitemid 38198742)
75. Kornblihtt AR (2006) Chromatin, transcript elongation and alternative splicing. Nat Struct Mol Biol 13:5-7 (Pubitemid 43049394)
76. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T (2010) Regulation of alternative splicing by histone modifications. Science 327:996-1000
77. Saint-André V, Batsché E, Rachez C, Muchardt C (2011) Histone H3 lysine 9 trimethylation and HP1c favor inclusion of alternative exons. Nat Struct Mol Biol 18:337-344
78. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-111 (Pubitemid 33041634)
79. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial- mesenchymal transition generates cells with properties of stem cells. Cell 133:704-715 (Pubitemid 351636299)
80. Turner N, Grose R (2010) Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10:116-129
81. Yan G, Fukabori Y,McBride G, Nikolaropolous S, McKeehan WL (1993) Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13:4513-4522 (Pubitemid 23220358)
82. Wagner EJ, Garcia-Blanco MA (2002) RNAi-mediated PTB depletion leads to enhanced exon definition. Mol Cell 10:943-994
83. Oltean S, Sorg BS, Albrecht T, Bonano VI, Brazas RM, Dewhirst MW, Garcia-Blanco MA (2006) Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proc Natl Acad Sci USA 103:14116-14121 (Pubitemid 44452989)
84. Del Gatto-Konczak F, Olive M, Gesnel M, Breathnach R (1999) hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol Cell Biol 19:251-260 (Pubitemid 29018427)
85. Carstens RP, Wagner EJ, Garcia-Blanco MA (2000) An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein. Mol Cell Biol 20:7388-7400
86. Mauger DM, Lin C, Garcia-Blanco MA (2008) hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc. Mol Cell Biol 28:5403-5419
87. Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP (2009) ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 33:591-601
88. Yanagisawa M, Huveldt D, Kreinest P, Lohse CM, Cheville JC, Parker AS, Copland JA, Anastasiadis PZ (2008) A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease. J Biol Chem 283:18344-18354
89. Weise A, Bruser K, Elfert S, Wallmen B, Wittel Y, Wöhrle S, Hecht A (2010) Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets. Nucleic Acids Res 38:1964-1981
90. Hirano M, Hashimoto S, Yonemura S, Sabe H, Aizawa S (2008) EPB41L5 functions to post-transcriptionally regulate cadherin and integrin during epithelial-mesenchymal transition. J Cell Biol 182:1217-1230
91. Mellman I, Nelson WJ (2008) Coordinated protein sorting, targeting and distribution in polarized cells. Natl Rev Mol Cell Biol 9:833-845